Leading Medisafe with scientific excellence & global expertise empowering tomorrow’s radiopharmaceutical care.
Our Board blends clinical, scientific, and strategic expertise from across the world. Each member contributes to advancing radioligand therapies & expanding access to cancer care globally. Together, they uphold world-class governance, research integrity & innovation while prioritizing patient outcomes.
Years Combined RLT Excellence
Global Academic Partners
Meet the visionaries guiding Medisafe’s strategic growth & scientific excellence.
25+ years oncology & radiopharma leadership. Former Novartis strategy leader.
Ex-AIIMS specialist; pioneered radiopharma clinical protocols across Asia & Europe.
Life-sciences investor supporting global clinical translation & oncology scale-up.
We uphold excellence through research, innovation, safety & global medical partnership.
Partner with us to transform outcomes & shape next-generation cancer care.